Promoter hypermethylation in sentinel lymph nodes as a marker for breast cancer recurrence

Breast Cancer Research and Treatment

Volumn 114, Issue 2, 2009, Pages 315-325

  Carraway, Hetty E ^a   Wang, Shelun ^b   Blackford, Amanda ^a   Guo, Mingzho ^a   Powers, Penny ^a   Jeter, Stacie ^a   Davidson, Nancy E ^a   Argani, Pedram ^c   Terrell, Kyle ^c   Herman, James G ^a   Lange, Julie R ^c  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b Institute of Oncology   (China)

^c JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Bisulfite treatment; CpG Island; DNA methylation; Epigenetics; Methylation specific PCR; Nested MSP; Sentinel node

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER RECURRENCE; DNA METHYLATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIMARY TUMOR; PRIORITY JOURNAL; PROMOTER REGION; RECURRENCE RISK; RECURRENT CANCER; SENTINEL LYMPH NODE;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; DNA METHYLATION; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POLYMERASE CHAIN REACTION; PROGNOSIS; PROMOTER REGIONS, GENETIC; PROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 59449110332     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-008-0004-7     Document Type: Article

References (47)

1. A Jemal R Siegel E Ward T Murray J Xu MJ Thun 2007 Cancer statistics, 2007 CA Cancer J Clin 57 1 43 66
2. M Shinozaki DS Hoon AE Giuliano NM Hansen HJ Wang R Turner B Taback 2005 Distinct hypermethylation profile of primary breast cancer is associated with sentinel lymph node metastasis Clin Cancer Res 11 6 2156 2162
3. B Cady MD Stone JG Schuler R Thakur MA Wanner PT Lavin 1996 The new era in breast cancer. Invasion, size, and nodal involvement dramatically decreasing as a result of mammographic screening Arch Surg 131 3 301 308
4. U Veronesi G Paganelli G Viale A Luini S Zurrida V Galimberti M Intra P Veronesi C Robertson P Maisonneuve 2003 A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer N Engl J Med 349 6 546 553
5. I Jatoi SG Hilsenbeck GM Clark CK Osborne 1999 Significance of axillary lymph node metastasis in primary breast cancer J Clin Oncol 17 8 2334 2340
6. CL Carter C Allen DE Henson 1989 Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases Cancer 63 1 181 187
7. Gnerlich J, Jeffe DB, Deshpande AD, Beers C, Zander C, Margenthaler JA (2007) Surgical removal of the primary tumor increases overall survival in patients with metastatic breast cancer: analysis of the 1988-2003 SEER data. Ann Surg Oncol 14(8):2187-2194
8. ER Fisher S Anderson C Redmond B Fisher 1993 Pathologic findings from the national surgical adjuvant breast project protocol B-06. 10-year pathologic and clinical prognostic discriminants Cancer 71 8 2507 2514
9. C Sotiriou SY Neo LM McShane EL Korn PM Long A Jazaeri P Martiat SB Fox AL Harris ET Liu 2003 Breast cancer classification and prognosis based on gene expression profiles from a population-based study Proc Natl Acad Sci USA 100 18 10393 10398
10. LJ van't Veer H Dai MJ van de Vijver YD He AA Hart M Mao HL Peterse K van der Kooy MJ Marton AT Witteveen 2002 Gene expression profiling predicts clinical outcome of breast cancer Nature 415 6871 530 536
11. MJ van de Vijver YD He LJ van't Veer H Dai AA Hart DW Voskuil GJ Schreiber JL Peterse C Roberts MJ Marton 2002 A gene-expression signature as a predictor of survival in breast cancer N Engl J Med 347 25 1999 2009
12. S Paik G Tang S Shak C Kim J Baker W Kim M Cronin FL Baehner D Watson J Bryant 2006 Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer J Clin Oncol 24 23 3726 3734
13. U Veronesi V Galimberti S Zurrida F Pigatto P Veronesi C Robertson 2001 Sentinel lymph node biopsy as an indicator for axillary dissection in early breast cancer Eur J Cancer 37 4 454 458
14. KM McMasters TM Tuttle DJ Carlson CM Brown RD Noyes RL Glaser DJ Vennekotter PS Turk PS Tate A Sardi 2000 Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used J Clin Oncol 18 13 2560 2566
15. D Krag D Weaver T Ashikaga F Moffat VS Klimberg C Shriver S Feldman R Kusminsky M Gadd J Kuhn 1998 The sentinel node in breast cancer-a multicenter validation study N Engl J Med 339 14 941 946
16. Groen RS, Oosterhuis AW, Boers JE (2007) Pathologic examination of sentinel lymph nodes in breast cancer by a single haematoxylin-eosin slide versus serial sectioning and immunocytokeratin staining: clinical implications. Breast Cancer Res Treat 100:229-235
17. AS Pargaonkar RS Beissner S Snyder VO Speights Jr 2003 Evaluation of immunohistochemistry and multiple-level sectioning in sentinel lymph nodes from patients with breast cancer Arch Pathol Lab Med 127 6 701 705
18. PR Rosen S Groshen PE Saigo DW Kinne S Hellman 1989 A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma J Clin Oncol 7 3 355 366
19. Herbert GS, Sohn VY, Brown TA (2007) The impact of nodal isolated tumor cells on survival of breast cancer patients. Am J Surg 193(5):571-573; discussion 573-574
20. HJ Kahn WM Hanna JA Chapman ME Trudeau HL Lickley BG Mobbs D Murray KI Pritchard CA Sawka DR McCready 2006 Biological significance of occult micrometastases in histologically negative axillary lymph nodes in breast cancer patients using the recent american joint committee on cancer breast cancer staging system Breast J 12 4 294 301
21. G Egger G Liang A Aparicio PA Jones 2004 Epigenetics in human disease and prospects for epigenetic therapy Nature 429 6990 457 463
22. AR Karpf DA Jones 2001 Reactivating the expression of methylation silenced genes in human cancer Oncogene 21 35 5496 5503
23. SB Baylin JG Herman 2001 Promoter hypermethylation-can this change alone ever designate true tumor suppressor gene function? J Natl Cancer Inst 93 9 664 665
24. PL Jones AP Wolffe 1999 Relationships between chromatin organization and DNA methylation in determining gene expression Semin Cancer Biol 9 5 339 347
25. LM Mielnicki HL Asch BB Asch 2001 Genes, chromatin, and breast cancer: An epigenetic tale J Mammary Gland Biol Neoplasia 6 2 169 182
26. X Yang L Yan NE Davidson 2001 DNA methylation in breast cancer Endocr Relat Cancer 8 2 115 127
27. M Widschwendter PA Jones 2002 DNA methylation and breast carcinogenesis Oncogene 21 35 5462 5482
28. M Sanchez-Cespedes M Esteller K Hibi FO Cope WH Westra S Piantadosi JG Herman J Jen D Sidransky 1999 Molecular detection of neoplastic cells in lymph nodes of metastatic colorectal cancer patients predicts recurrence Clin Cancer Res 5 9 2450 2454
29. JG Herman JR Graff S Myohanen BD Nelkin SB Baylin 1996 Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands Proc Natl Acad Sci USA 93 18 9821 9826
30. EO Machida MV Brock CM Hooker J Nakayama A Ishida J Amano MA Picchi SA Belinsky JG Herman S Taniguchi 2006 Hypermethylation of ASC/TMS1 is a sputum marker for late-stage lung cancer Cancer Res 66 12 6210 6218
31. M van Engeland MP Weijenberg GM Roemen M Brink AP de Bruine RA Goldbohm PA Van den Brandt SB Baylin AF de Goeij JG Herman 2003 Effects of dietary folate and alcohol intake on promoter methylation in sporadic colorectal cancer: The Netherlands cohort study on diet and cancer Cancer Res 63 12 3133 3137
32. LM McShane DG Altman W Sauderbrei S Taube M Gion G Clark 2006 Reporting recommendations for tumor MARKer prognostic studies (REMARK) Breast Cancer Res Treat 100 229 235
33. JR Caldeira EC Prando FC Quevedo FA Moraes Netto CA Rainho SR Rogatto 2006 CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer BMC Cancer 6 1 48
34. DB Douglas Y Akiyama H Carraway SA Belinsky M Esteller E Gabrielson S Weitzman T Williams JG Herman SB Baylin 2004 Hypermethylation of a small CpGuanine-rich region correlates with loss of activator protein-2alpha expression during progression of breast cancer Cancer Res 64 5 1611 1620
35. JR Graff JG Herman RG Lapidus H Chopra R Xu DF Jarrard WB Isaacs PM Pitha NE Davidson SB Baylin 1995 E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas Cancer Res 55 22 5195 5199
36. JG Herman A Merlo L Mao RG Lapidus JP Issa NE Davidson D Sidransky SB Baylin 1995 Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers Cancer Res 55 20 4525 4530
37. MS Jhaveri CS Morrow 1998 Methylation-mediated regulation of the glutathione S-transferase P1 gene in human breast cancer cells Gene 210 1 1 7
38. IE Krop D Sgroi DA Porter KL Lunetta R LeVangie P Seth CM Kaelin E Rhei M Bosenberg S Schnitt 2001 HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells Proc Natl Acad Sci USA 98 17 9796 9801
39. CM Lewis LR Cler DW Bu S Zochbauer-Muller S Milchgrub EZ Naftalis AM Leitch JD Minna DM Euhus 2005 Promoter hypermethylation in benign breast epithelium in relation to predicted breast cancer risk Clin Cancer Res 11 1 166 172
40. W Yeo WL Wong N Wong BK Law GM Tse S Zhong 2005 High frequency of promoter hypermethylation of RASSF1A in tumorous and non-tumourous tissue of breast cancer Pathology 37 2 125 130
41. S Zochbauer-Muller KM Fong A Maitra S Lam J Geradts R Ashfaq AK Virmani S Milchgrub AF Gazdar JD Minna 2001 5' CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer Cancer Res 61 9 3581 3585
42. H Berman J Zhang YG Crawford ML Gauthier CA Fordyce KM McDermott M Sigaroudinia K Kozakiewicz TD Tlsty 2005 Genetic and epigenetic changes in mammary epithelial cells identify a subpopulation of cells involved in early carcinogenesis Cold Spring Harb Symp Quant Biol 70 317 327
43. R Aoki M Yasuda R Torisu J Nakamoto Y Yamamoto S Ito 2007 Relationship between lymph node metastasis and E-cadherin expression in submucosal invasive gastric carcinomas with gastric-phenotype J Med Invest 54 1-2 159 167
44. J Pellikainen V Kataja K Ropponen J Kellokoski T Pietilainen J Bohm M Eskelinen VM Kosma 2002 Reduced nuclear expression of transcription factor AP-2 associates with aggressive breast cancer Clin Cancer Res 8 11 3487 3495
45. IJ Bleiweiss CS Nagi S Jaffer 2006 Axillary sentinel lymph nodes can be falsely positive due to iatrogenic displacement and transport of benign epithelial cells in patients with breast carcinoma J Clin Oncol 24 13 2013 2018
46. NM Diaz V Vrcel BA Centeno C Muro-Cacho 2005 Modes of benign mechanical transport of breast epithelial cells to axillary lymph nodes Adv Anat Pathol 12 1 7 9
47. BA Carter RA Jensen JF Simpson DL Page 2000 Benign transport of breast epithelium into axillary lymph nodes after biopsy Am J Clin Pathol 113 2 259 265